Curcumin induces p53-independent necrosis in H1299 cells via a mitochondria-associated pathway

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 7806-7814

  Li, Feie ^a   Chen, Xi ^a   Xu, Bing ^a   Zhou, Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

B cell lymphoma 2 associated X protein; Curcumin; H1299 cells; Mitochodria; Necrosis

Indexed keywords

CURCUMIN; CYTOCHROME C; PROTEIN BAK; PROTEIN BAX; PROTEIN P53; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT; CASPASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL DEATH; CELL PROLIFERATION; CYTOTOXICITY; DIET SUPPLEMENTATION; EMBRYO DEVELOPMENT; FLOW CYTOMETRY; GENE SILENCING; LUNG CANCER CELL LINE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MTT ASSAY; OLIGOMERIZATION; RADIOIMMUNOPRECIPITATION; WESTERN BLOTTING; DRUG EFFECTS; HUMAN; LUNG; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL DEATH; CELL PROLIFERATION; CURCUMIN; CYTOCHROMES C; HUMANS; LUNG; LUNG NEOPLASMS; MITOCHONDRIA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84943644813     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4395     Document Type: Article

References (44)

1. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K and McKenna SL: Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101: 1585-1595, 2009.
2. Friedman L, Lin L, Ball S, Bekaii-Saab T, Fuchs J, Li PK, Li C and Lin J: Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells. Anticancer Drugs 20: 444-449, 2009.
3. Steward WP and Gescher AJ: Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research. Mol Nutr Food Res 52: 1005-1009, 2008.
4. Shehzad A, Lee J, Huh TL and Lee YS: Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53. Mol Cells 35: 526-532, 2013.
5. Choudhuri T, Pal S, Agwarwal ML, Das T and Sa G: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512: 334-340, 2002.
6. Alenzi FQ, Wyse RK and Altamimi WG: Apoptosis as a tool for therapeutic agents in haematological diseases. Expert Opin Biol Ther 4: 407-420, 2004.
7. Huang S, Shao K, Liu Y, Kuang Y, Li J, An S, Guo Y, Ma H and Jiang C: Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis. ACS Nano 7: 2860-2871, 2013.
8. Griffith TS: Induction of tumor cell apoptosis by TRAIL gene therapy. Methods Mol Biol 542: 315-334, 2009.
9. Sosna J, Voigt S, Mathieu S, Lange A, Thon L, Davarnia P, Herdegen T, Linkermann A, Rittger A, Chan FK, et al: TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci 71: 331-348, 2014.
10. Proskuryakov SY, Gabai VL and Konoplyannikov AG: Necrosis is an active and controlled form of programmed cell death. Biochemistry (Mosc) 67: 387-408, 2002.
11. Vandenabeele, P., W. Declercq, F. Van Herreweghe, et al. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal. 2010; 115: re4.
12. Baritaud M, Boujrad H, Lorenzo HK, Krantic S and Susin SA: Histone H2AX: The missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle 9: 3166-3173, 2010.
13. Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T and Sato Y: Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci 100: 349-356, 2009.
14. Nicotera P and Melino G: Regulation of the apoptosis-necrosis switch. Oncogene 23: 2757-2765, 2004.
15. Lin X, Sun T, Cai M and Shen P: Cell-death-mode switch from necrosis to apoptosis in hydrogen peroxide treated macrophages. Sci China Life Sci 53: 1196-1203, 2010.
16. Bergeron L, Perez GI, Macdonald G, et al: Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12: 1304-1314, 1998.
17. Hosseinimehr SJ, Azadbakht M, Tanha M, Mahmodzadeh A and Mohammadifar S: Protective effect of hawthorn extract against genotoxicity induced by methyl methanesulfonate in human lymphocytes. Toxicol Ind Health 27: 363-369, 2010.
18. Kosmider B, Wojcik I, Osiecka R, Bartkowiak J, Zyner E, Ochocki J and Liberski P: Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Invest New Drugs 23: 287-297, 2005.
19. Song G, Mao YB, Cai QF, Yao LM, Ouyang GL and Bao SD: Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38: 1791-1798, 2005.
20. Yu JL, Rak JW, Coomber BL, et al: Effect of p53 status on tumor response to antiangiogenic therapy. Science 295:1526-1528, 2002.
21. Tian F, Song M, Xu PR, et al: [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway]. Ai Zheng 27: 566-570, 2008 (In Chinese).
22. Zhang W, Liu N, Wang X, et al: Benzo(a)pyrene-7,8-diol-9,10-epoxide induced p53-independent necrosis via the mitochondria-associated pathway involving Bax and Bak activation. Hum Exp Toxicol 34: 179-190, 2015.
23. Guo BC and Xu YH: Bcl-2 over-expression and activation of protein kinase C suppress the trail-induced apoptosis in Jurkat T cells. Cell Res 11: 101-106, 2001.
24. Bar-Sela G, Epelbaum R and Schaffer M: Curcumin as an anti-cancer agent: Review of the gap between basic and clinical applications. Curr Med Chem 17: 190-197, 2010.
25. Tian C, Xing G, Xie P, et al: KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol 11: 580-591, 2009.
26. Blankenberg FG: Apoptosis imaging: Anti-cancer agents in medicinal chemistry. Anticancer Agents Med Chem 9: 944-951, 2009.
27. Meulmeester E and Jochemsen AG: p53: A guide to apoptosis. Curr Cancer Drug Targets 8: 87-97, 2008.
28. Xu Y: Regulation of p53 responses by post-translational modifications. Cell Death Differ 10: 400-403, 2003.
29. Leibowitz BJ, Qiu W, Liu H, Cheng T, Zhang L and Yu J: Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21. Mol Cancer Res 9: 616-625, 2011.
30. Thakur VS, Ruhul Amin AR, Paul RK, Gupta K, Hastak K, Agarwal MK, Jackson MW, Wald DN, Mukhtar H and Agarwal ML: p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer Lett 296: 225-232, 2010.
31. Morales-Cruz M, Figueroa CM, Gonzalez-Robles T, et al: Activation of caspase-dependent apoptosis by intracellular delivery of cytochrome c-based nanoparticles. J Nanobiotechnology 12: 33, 2014.
32. Antignani A and Youle RJ: How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Cell Biol 18: 685-689, 2006.
33. Holcakova J, Ceskova P, Hrstka R, Muller P, Dubska L, Coates PJ, Palecek E and Vojtesek B: The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis. Cell Mol Biol Lett 13: 404-420, 2008.
34. Kim GT, Lee SH, Kim JI and Kim YM: Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner. Int J Mol Med 33: 863-869, 2014.
35. Kim H, Tu HC, Ren D, et al: Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 36: 487-499, 2009.
36. Antonsson B, Montessuit S, Lauper S, et al: Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345 (Pt 2): 271-278, 2000.
37. Sundararajan R, Cuconati A, Nelson D and White E: Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J Biol Chem 276: 45120-45127, 2001.
38. Wachter F, Grunert M, Blaj C, Weinstock DM, Jeremias I and Ehrhardt H: Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling. Cell Commun Signal 11: 27, 2013.
39. Mehmeti I, Gurgul-Convey E, Lenzen S and Lortz S: Induction of the intrinsic apoptosis pathway in insulin-secreting cells is dependent on oxidative damage of mitochondria but independent of caspase-12 activation. Biochim Biophys Acta 1813: 1827-1835, 2011.
40. Buratta M, Castigli E, Sciaccaluga M, Pellegrino RM, Spinozzi F, Roberti R and Corazzi L: Loss of cardiolipin in palmitate-treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to apoptosis. J Neurochem 105: 1019-1031, 2008.
41. Lee HJ, Lee HJ, Lee EO, Ko SG, Bae HS, Kim CH, Ahn KS, Lu J and Kim SH: Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Lett 270: 342-353, 2008.
42. Nakabayashi J and Sasaki A: A mathematical model for apoptosome assembly: The optimal cytochrome c/Apaf-1 ratio. J Theor Biol 242: 280-287, 2006.
43. Adrain C and Martin SJ: The mitochondrial apoptosome: A killer unleashed by the cytochrome seas. Trends Biochem Sci 26: 390-397, 2001.
44. Kihana T, Tsuda H, Teshima S, et al: High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Jpn J Cancer Res 83: 978-984, 1992.